Japanese firm touts anticancer drug success in humans
A Tokyo based pharmaceutical firm and Kanazawa University researchers report successful human testing of a new anticancer drug. Lead researcher Prof Hamime Okamoto says several patients showed drastic improvement while others had slower responses and notes animal testing showed consistent effectiveness. The company claims the drug targets cancer cells while sparing healthy tissue, calling it superior to existing treatments.
MENTIONED IN THIS ARTICLE
Tokyo
Hamime Okamoto
Kanazawa University
School of Medicine
Kanazawa University Hospital
Japan
Okamoto
Also Mentioned on This Page
Chugai Seiyaku Pharmaceutical Co
Lou G. Bertane
Internal Revenue Agent
8Th St
Herrin, Ill
Food Center
S. Wall
Walnut
Carbondale
Wisbury
DR. Pepper
Chase
Sanborn
Friskies
Cen
Kelley
Philadelphia
Pillsbury OR
Ballard Biscuits
Campbell
Pride OF
Illinois
Florida
McCormick Pure
U. S. Choice
Chuck
U.S
MERIT
Saltine
PUREX
Swift Premium Wieners
Asc
Mayrose Braunschweiger
Bologna
Mayrose Buffet
Ange